|
|
|
Volumn 92, Issue 12, 1997, Pages 2314-2315
|
|
Why do we need a newer generation of recombinant vaccines against hepatitis B?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEPATITIS B ANTIBODY;
HEPATITIS B VACCINE;
IMMUNOLOGICAL ADJUVANT;
RECOMBINANT VACCINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HEPATITIS B;
HUMAN;
IMMUNIZATION;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
VACCINATION;
ADJUVANTS, IMMUNOLOGIC;
ADOLESCENT;
ADULT;
AGED;
COHORT STUDIES;
HEPATITIS B;
HEPATITIS B ANTIBODIES;
HEPATITIS B VACCINES;
HUMANS;
IMMUNIZATION, SECONDARY;
MIDDLE AGED;
VACCINATION;
VACCINES, SYNTHETIC;
|
|
EID: 0031465839
PISSN: 00029270
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
